Your trustworthy licensing partner for China
China is the world's second-largest and fastest-growing pharmaceutical market. Licensing out to a strong Chinese partner enables faster market entry, access to a vast patient pool, and maximized commercial value for your pipeline.
At JMSS, we specialize in connecting Korean biopharma with leading Chinese pharmaceutical companies, structuring optimal deals, and ensuring seamless regulatory navigation. With deep industry connections and scientific expertise, we help you unlock China’s market potential while minimizing risks at a competitive cost.
We deliver highest quality solutions through specialized biomedical expertise, in-depth market analytics, a robust network of industry leaders, and transparent communication.
We identify innovative biomedical products and strategically license them to leading Chinese biopharmaceutical companies, delivering exceptional client returns.
To become the uniquely cost-effective, Korea based pharmaceutical licensing service with the highest success rate in the industry.
Service Flow Chart